Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance

E-ISSN： 1532-6535|94|5|601-609

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.94, Iss.5, 2013-11, pp. : 601-609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Midazolam microdosing

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 2, 2015-02 ,pp. : 278-285

John Wiley & Sons Inc

Access to resources Recommend Favorite

Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β‐hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 41, Iss. 5, 2016-10 ,pp. : 552-558

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Trigonella foenum-graecum L. on Metabolic Activity of CYP2D6 and CYP3A4

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 22, Iss. 3, 2015-06 ,pp. : 180-184

Karger

Access to resources Recommend Favorite

Effect of brivaracetam on CYP3A activity, measured by oral midazolam

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 5, 2015-05 ,pp. : 543-548

John Wiley & Sons Inc

Access to resources Recommend Favorite

In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 5, 2015-11 ,pp. : 1122-1130

John Wiley & Sons Inc

Access to resources Recommend Favorite